Patient characteristics
| Subject no. . | Sex . | Race/ethnicity . | Age, y . | Risk factors . | Viral load* . | CD4+ T-cell count* . |
|---|---|---|---|---|---|---|
| 20-1 | M | White | 50 | IVDU | 4.4 × 103 | 215 |
| 23-2 | M | White | 32 | MSM | 1.0 × 103 | 726 |
| 8-1 | M | Black | 24 | MSM | 1.3 × 104 | 412 |
| 19-1 | M | White | 37 | IVDU | 2.2 × 104 | 705 |
| 10 | M | White | 32 | MSM/IVDU | 2.9 × 104 | 342 |
| 5-1 | M | White | 24 | IVDU/MSM | 3.5 × 104 | 282 |
| 13-1 | M | White | 38 | MSM/IVDU | 4.6 × 104 | 107 |
| 24 | M | Hispanic | 23 | MSM | 4.9 × 104 | 478 |
| 1-1 | M | White | 37 | MSM | 7.4 × 104 | 169 |
| 3-1 | M | Black | 43 | MSM | 1.5 × 105 | 464 |
| Subject no. . | Sex . | Race/ethnicity . | Age, y . | Risk factors . | Viral load* . | CD4+ T-cell count* . |
|---|---|---|---|---|---|---|
| 20-1 | M | White | 50 | IVDU | 4.4 × 103 | 215 |
| 23-2 | M | White | 32 | MSM | 1.0 × 103 | 726 |
| 8-1 | M | Black | 24 | MSM | 1.3 × 104 | 412 |
| 19-1 | M | White | 37 | IVDU | 2.2 × 104 | 705 |
| 10 | M | White | 32 | MSM/IVDU | 2.9 × 104 | 342 |
| 5-1 | M | White | 24 | IVDU/MSM | 3.5 × 104 | 282 |
| 13-1 | M | White | 38 | MSM/IVDU | 4.6 × 104 | 107 |
| 24 | M | Hispanic | 23 | MSM | 4.9 × 104 | 478 |
| 1-1 | M | White | 37 | MSM | 7.4 × 104 | 169 |
| 3-1 | M | Black | 43 | MSM | 1.5 × 105 | 464 |
IVDU indicates intravenous drug user; and MSM, men having sex with men.
At the time of LN biopsy during chronic HIV infection.